Cole, Graham B.
Satyamurthy, Nagichettiar
Liu, Jie
Wong, Koon-Pong
Small, Gary W.
Huang, Sung-Cheng
Košmrlj, Janez
Barrio, Jorge R.
Petrič, Andrej http://orcid.org/0000-0001-5294-9902
Funding for this research was provided by:
Javna Agencija za Raziskovalno Dejavnost RS (P1-0230)
Javna Agencija za Raziskovalno Dejavnost RS (J1-8147)
National Institutes of Health (P01-AG025831, AG13308, P50 AG 16570, MH/ AG58156, MH52453, AG10123)
U.S. Department of Energy (DE-FC03-87- ER60615)
Article History
First Online: 31 May 2018
Compliance with Ethical Standards
:
: The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled “Methods for Labeling β-Amyloid Plaques and Neurofibrillary Tangles,” which has been licensed to TauMark, LLC. N.S., G.W.S., S.-C.H., A.P., and J.R.B. are among the inventors. N.S., S.-C.H., G.W.S., and J.R.B. have equity interest in TauMark, LLC. All other authors report no financial conflicts of interest.